HOME SITEMAP FEEDBACK ARCHIVES MEDIA KIT SUBSCRIBE
Search:     Help
Advertisement
 
Home > Ventures
Ventures
"Govt should encourage VCs for seed capital investments"


Life sciences sector in the US attracts largest investment in Q3, 2005


Pfizer acquires Bioren


VC investments in life sciences rise to $2.5 billion


Search for Profits


Search for Profits


"TDB's role encompasses that of a venture capitalist and a financial institution but is still broader in scope"


TDB a premier institution promoting "BioVentures"


DST Seeks Advice On Usage of R&D Fund


VC investing in life sciences rises to $5.6 billion in 2004

According to the MoneyTree Survey by Pricewaterhouse-Coopers, Thomson Venture Economics and the National Venture Capital Association, venture capitalists reversed a three-year downward trend by investing $20.9 billion into 2,876 deals in 2004. The Life Sciences sector (biotechnology and medical Devices industries, together) dominated the field accounting for 27 percent of all venture capital dollars. Investments in this sector in the fourth quarter increased to $1.5 billion. For full year 2004, the sector totaled $5.6 billion in 578 companies, the largest dollars and deals in four years.


Johnson & Johnson to acquire Guidant

Johnson & Johnson and Guidant Corp., a world leader in the treatment of cardiac and vascular disease, have entered into a definitive agreement whereby Johnson & Johnson will acquire Guidant for $25.4 billion in fully diluted equity value.


Monsanto to invest in regional seed firms
Current Issue
Current Issue

Advertisement

Read Testimonials
EDITORIAL
BIONEWS
EVENTS

Advertisement




Google Web biospectrumindia.com
Other CyberMedia websites
 Dataquest |  Voice&Data |  PCQuest |  Living Digital |  DQ Channels |  The DQweek
CIOL |  IDC India |  CyberMedia Careers |  CyberMedia Events |  CyberMedia Digital
Cyber Astro |  CyberMedia India |  Global Services |  BioSpectrum Asia

About BioSpectrum | Feedback | Contact Us

 
Copyright © CyberMedia All rights reserved. 
Reproduction in whole or in part in any form or medium without express written permission is prohibited. 
Usage of this web site is subject to terms and conditions.

Broken links? Problem with site? Send email to webmaster@cybermedia.co.in